Novo Nordisk is cutting the price of its weight-loss drug, Wegovy, and selling it through a direct-to-patient online pharmacy ...
Novo Nordisk A/S (NVO) has slashed prices for its blockbuster weight-loss drug Wegovy as competition in the obesity drug market heats up, with ...
a 56% increase over sales in the prior year. The vast majority of that revenue came from Wegovy. The pharma giant wants to protect that revenue from competitors. Its new Wegovy offering is the ...
NovoCare Pharmacy will provide all dose strengths of Wegovy at a reduced cost of $499 per month for cash-paying patients ...
Makers of the popular obesity treatments Wegovy and Zepbound are cutting prices for people ... people shed weight by ...
Novo Nordisk’s breakneck sales growth has continued in the first quarter of this year with a 24% increase that was helped by a doubling in turnover of obesity blockbuster Wegovy. Group revenues ...
Wegovy and Ozempic, a declaration that will curtail widespread sales of cheaper copies made by compounding pharmacies. Shares of Hims & Hers Health HIMS.N, which advertised its compounded ...